Summary

The global Humanized Liver Mice Model Market is witnessing substantial growth as pharmaceutical companies, biotechnology organizations, and research institutions continue to increase investments in sophisticated preclinical research technologies. Humanized liver mice models are extensively utilized in drug metabolism studies, toxicology testing, infectious disease research, and liver disease investigations. These advanced models closely mimic human liver functions, allowing researchers to study disease progression and therapeutic responses with improved precision. The growing focus on precision medicine, increasing biologics production, and rising demand for efficient translational research platforms are significantly contributing to market expansion across both developed and emerging economies.

Market Insights

The Humanized Liver Mice Model Market is expected to reach US$ 121.3 Mn in 2026 and further expand to US$ 197.3 Mn by 2033, growing at a CAGR of 7.20% during the forecast period. The market is experiencing steady growth due to the rising need for predictive animal models in pharmaceutical research and the increasing emphasis on minimizing clinical trial failures. Humanized liver mice models play a crucial role in assessing drug induced liver toxicity, pharmacokinetics, and therapeutic efficacy before clinical testing in humans. Moreover, ongoing advancements in genetic engineering technologies and animal modeling techniques are enhancing the accuracy, scalability, and effectiveness of these research solutions.

Market Drivers

One of the key factors driving the Humanized Liver Mice Model Market is the increasing incidence of chronic liver disorders and viral infections globally. Researchers are increasingly adopting these models to investigate conditions such as hepatitis, liver fibrosis, nonalcoholic steatohepatitis, and hepatocellular carcinoma with enhanced reliability. Another significant driver is the rapid growth of biologics and cell therapy development pipelines. Pharmaceutical and biotechnology companies require advanced research models capable of accurately replicating human liver metabolism for safety analysis and efficacy testing.

The growing adoption of personalized medicine is also supporting market growth. Humanized liver mice models help researchers evaluate patient specific responses to therapies, enabling the development of targeted treatment approaches. In addition, increasing government support for biomedical research and rising collaborations between academic institutions and biotechnology firms are accelerating technological advancements in the market.

Business Opportunity

The Humanized Liver Mice Model Market offers considerable growth opportunities for organizations involved in contract research services, genetic engineering, and laboratory technology solutions. Companies are focusing on introducing customized humanized liver mice models designed for specific therapeutic and research applications. The increasing demand for outsourced preclinical testing services is also creating favorable opportunities for contract research organizations specializing in advanced animal models.

Emerging economies are expected to provide significant business potential due to expanding healthcare infrastructure and rising pharmaceutical research investments. Increasing interest in immuno oncology studies and infectious disease research is encouraging market players to develop innovative mouse models with improved human liver functionality. Strategic partnerships, acquisitions, and collaborative research agreements are anticipated to remain major strategies for companies aiming to strengthen their market presence and technological capabilities.

Region Analysis

North America continues to hold a dominant position in the Humanized Liver Mice Model Market due to strong pharmaceutical research activities, advanced biotechnology infrastructure, and substantial investments in biomedical innovation. The United States remains a major contributor to regional growth because of increasing drug discovery initiatives and the strong presence of leading biotechnology companies and academic research institutions.

Europe also represents a significant share of the market, supported by growing clinical research activities and favorable government initiatives promoting life sciences research. Countries including Germany, the United Kingdom, and France are witnessing increased adoption of advanced preclinical research models across pharmaceutical and academic sectors.

The Asia Pacific region is projected to witness notable growth throughout the forecast period. Expanding pharmaceutical manufacturing capabilities, increasing research collaborations, and growing biotechnology investments are driving regional market development. Countries such as China, Japan, South Korea, and India are emerging as important markets due to the rapid expansion of biomedical research and contract research services.

Key Players

Major companies operating in the Humanized Liver Mice Model Market are concentrating on product innovation, strategic collaborations, and portfolio expansion to strengthen their competitive position. Leading market participants include:

• Ingenious Targeting Laboratory

• Axenis S.A.S

• Trans Genic Inc.

• Horizon Discovery Group PLC

• HuMurine Technologies

• Champions Oncology Inc.

• Genoway S.A.

• Crown Bioscience Inc.

• Taconic Biosciences Inc.

• The Jackson Laboratory

• Vitalstar Biotechnology Co. Ltd.

These organizations are actively investing in advanced gene editing technologies and improved liver engraftment techniques to enhance model performance and research outcomes. Companies are also focusing on offering customized solutions and integrated research services to address the evolving needs of pharmaceutical and biotechnology clients.

Future Outlook

The future outlook for the Humanized Liver Mice Model Market remains highly positive as advancements in regenerative medicine, stem cell technology, and artificial intelligence based drug discovery continue to transform preclinical research processes. Market participants are expected to prioritize the development of next generation models with enhanced immune system integration and improved liver functionality. Rising regulatory emphasis on accurate safety assessment and translational efficiency is anticipated to further boost market demand across pharmaceutical and biotechnology industries. Additionally, growing awareness regarding the limitations of traditional animal models is encouraging wider adoption of humanized liver mice models for complex disease research and precision therapy development.

Market Segmentation

By Model Type

• Genetic

• Cell Based

By Application

• Oncology

• Immunology

• Neuroscience

By End User

• Research Institutes

• Biotech Companies

• Hospitals

By Region

• North America

• Europe

• East Asia

• South Asia & Oceania

• Latin America

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Humanized Liver Mice Model Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Humanized Liver Mice Model Market Outlook, 2020 - 2033
3.1. Global Humanized Liver Mice Model Market Outlook, by Model Type, Value (US$ Mn), 2020-2033
3.1.1. Genetic
3.1.2. Cell Based
3.2. Global Humanized Liver Mice Model Market Outlook, by Application, Value (US$ Mn), 2020-2033
3.2.1. Oncology
3.2.2. Immunology
3.2.3. Neuroscience
3.2.4. Dermatology Research
3.2.5. Cardiovascular Disease & Diabetes
3.2.6. Cell therapy and Ex vivo manufacturing
3.2.7. Others
3.3. Global Humanized Liver Mice Model Market Outlook, by End User, Value (US$ Mn), 2020-2033
3.3.1. Research Institutes
3.3.2. Biotech Companies
3.3.3. Hospitals
3.4. Global Humanized Liver Mice Model Market Outlook, by Region, Value (US$ Mn), 2020-2033
3.4.1. North America
3.4.2. Europe
3.4.3. Asia Pacific
3.4.4. Latin America
3.4.5. Middle East & Africa
4. North America Humanized Liver Mice Model Market Outlook, 2020 - 2033
4.1. North America Humanized Liver Mice Model Market Outlook, by Model Type, Value (US$ Mn), 2020-2033
4.1.1. Genetic
4.1.2. Cell Based
4.2. North America Humanized Liver Mice Model Market Outlook, by Application, Value (US$ Mn), 2020-2033
4.2.1. Oncology
4.2.2. Immunology
4.2.3. Neuroscience
4.2.4. Dermatology Research
4.2.5. Cardiovascular Disease & Diabetes
4.2.6. Cell therapy and Ex vivo manufacturing
4.2.7. Others
4.3. North America Humanized Liver Mice Model Market Outlook, by End User, Value (US$ Mn), 2020-2033
4.3.1. Research Institutes
4.3.2. Biotech Companies
4.3.3. Hospitals
4.4. North America Humanized Liver Mice Model Market Outlook, by Country, Value (US$ Mn), 2020-2033
4.4.1. U.S. Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
4.4.2. U.S. Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
4.4.3. U.S. Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
4.4.4. Canada Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
4.4.5. Canada Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
4.4.6. Canada Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Humanized Liver Mice Model Market Outlook, 2020 - 2033
5.1. Europe Humanized Liver Mice Model Market Outlook, by Model Type, Value (US$ Mn), 2020-2033
5.1.1. Genetic
5.1.2. Cell Based
5.2. Europe Humanized Liver Mice Model Market Outlook, by Application, Value (US$ Mn), 2020-2033
5.2.1. Oncology
5.2.2. Immunology
5.2.3. Neuroscience
5.2.4. Dermatology Research
5.2.5. Cardiovascular Disease & Diabetes
5.2.6. Cell therapy and Ex vivo manufacturing
5.2.7. Others
5.3. Europe Humanized Liver Mice Model Market Outlook, by End User, Value (US$ Mn), 2020-2033
5.3.1. Research Institutes
5.3.2. Biotech Companies
5.3.3. Hospitals
5.4. Europe Humanized Liver Mice Model Market Outlook, by Country, Value (US$ Mn), 2020-2033
5.4.1. Germany Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
5.4.2. Germany Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
5.4.3. Germany Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
5.4.4. Italy Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
5.4.5. Italy Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
5.4.6. Italy Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
5.4.7. France Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
5.4.8. France Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
5.4.9. France Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
5.4.10. U.K. Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
5.4.11. U.K. Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
5.4.12. U.K. Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
5.4.13. Spain Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
5.4.14. Spain Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
5.4.15. Spain Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
5.4.16. Russia Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
5.4.17. Russia Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
5.4.18. Russia Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
5.4.19. Rest of Europe Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
5.4.20. Rest of Europe Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
5.4.21. Rest of Europe Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Humanized Liver Mice Model Market Outlook, 2020 - 2033
6.1. Asia Pacific Humanized Liver Mice Model Market Outlook, by Model Type, Value (US$ Mn), 2020-2033
6.1.1. Genetic
6.1.2. Cell Based
6.2. Asia Pacific Humanized Liver Mice Model Market Outlook, by Application, Value (US$ Mn), 2020-2033
6.2.1. Oncology
6.2.2. Immunology
6.2.3. Neuroscience
6.2.4. Dermatology Research
6.2.5. Cardiovascular Disease & Diabetes
6.2.6. Cell therapy and Ex vivo manufacturing
6.2.7. Others
6.3. Asia Pacific Humanized Liver Mice Model Market Outlook, by End User, Value (US$ Mn), 2020-2033
6.3.1. Research Institutes
6.3.2. Biotech Companies
6.3.3. Hospitals
6.4. Asia Pacific Humanized Liver Mice Model Market Outlook, by Country, Value (US$ Mn), 2020-2033
6.4.1. China Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
6.4.2. China Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
6.4.3. China Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
6.4.4. Japan Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
6.4.5. Japan Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
6.4.6. Japan Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
6.4.7. South Korea Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
6.4.8. South Korea Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
6.4.9. South Korea Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
6.4.10. India Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
6.4.11. India Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
6.4.12. India Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
6.4.13. Southeast Asia Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
6.4.14. Southeast Asia Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
6.4.15. Southeast Asia Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
6.4.16. Rest of SAO Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
6.4.17. Rest of SAO Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
6.4.18. Rest of SAO Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Humanized Liver Mice Model Market Outlook, 2020 - 2033
7.1. Latin America Humanized Liver Mice Model Market Outlook, by Model Type, Value (US$ Mn), 2020-2033
7.1.1. Genetic
7.1.2. Cell Based
7.2. Latin America Humanized Liver Mice Model Market Outlook, by Application, Value (US$ Mn), 2020-2033
7.2.1. Oncology
7.2.2. Immunology
7.2.3. Neuroscience
7.2.4. Dermatology Research
7.2.5. Cardiovascular Disease & Diabetes
7.2.6. Cell therapy and Ex vivo manufacturing
7.2.7. Others
7.3. Latin America Humanized Liver Mice Model Market Outlook, by End User, Value (US$ Mn), 2020-2033
7.3.1. Research Institutes
7.3.2. Biotech Companies
7.3.3. Hospitals
7.4. Latin America Humanized Liver Mice Model Market Outlook, by Country, Value (US$ Mn), 2020-2033
7.4.1. Brazil Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
7.4.2. Brazil Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
7.4.3. Brazil Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
7.4.4. Mexico Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
7.4.5. Mexico Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
7.4.6. Mexico Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
7.4.7. Argentina Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
7.4.8. Argentina Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
7.4.9. Argentina Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
7.4.10. Rest of LATAM Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
7.4.11. Rest of LATAM Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
7.4.12. Rest of LATAM Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Humanized Liver Mice Model Market Outlook, 2020 - 2033
8.1. Middle East & Africa Humanized Liver Mice Model Market Outlook, by Model Type, Value (US$ Mn), 2020-2033
8.1.1. Genetic
8.1.2. Cell Based
8.2. Middle East & Africa Humanized Liver Mice Model Market Outlook, by Application, Value (US$ Mn), 2020-2033
8.2.1. Oncology
8.2.2. Immunology
8.2.3. Neuroscience
8.2.4. Dermatology Research
8.2.5. Cardiovascular Disease & Diabetes
8.2.6. Cell therapy and Ex vivo manufacturing
8.2.7. Others
8.3. Middle East & Africa Humanized Liver Mice Model Market Outlook, by End User, Value (US$ Mn), 2020-2033
8.3.1. Research Institutes
8.3.2. Biotech Companies
8.3.3. Hospitals
8.4. Middle East & Africa Humanized Liver Mice Model Market Outlook, by Country, Value (US$ Mn), 2020-2033
8.4.1. GCC Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
8.4.2. GCC Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
8.4.3. GCC Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
8.4.4. South Africa Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
8.4.5. South Africa Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
8.4.6. South Africa Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
8.4.7. Egypt Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
8.4.8. Egypt Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
8.4.9. Egypt Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
8.4.10. Nigeria Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
8.4.11. Nigeria Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
8.4.12. Nigeria Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
8.4.13. Rest of Middle East Humanized Liver Mice Model Market Outlook, by Model Type, 2020-2033
8.4.14. Rest of Middle East Humanized Liver Mice Model Market Outlook, by Application, 2020-2033
8.4.15. Rest of Middle East Humanized Liver Mice Model Market Outlook, by End User, 2020-2033
8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Ingenious Targeting Laboratory
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Axenis S.A.S
9.4.3. Trans Genic Inc.
9.4.4. Horizon Discovery Group PLC
9.4.5. HuMurine Technologies
9.4.6. Champions Oncology Inc.
9.4.7. Genoway S.A.
9.4.8. Crown Bioscience Inc.
9.4.9. Taconic Biosciences Inc.
9.4.10. The Jackson Laboratory
9.4.11. Vitalstar Biotechnology Co. Ltd.
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations